PCN8 QUALITY OF LIFE-ADJUSTED SURVIVAL FOR FIRST LINE TREATMENT WITH RITUXIMAB PLUS CYCLOPHOSPHAMIDE AND VINCRISTINE (CVP) VERSUS CVP ALONE FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
Nov 1, 2008, 00:00
10.1016/S1098-3015(10)66546-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)66546-1/fulltext
Title :
PCN8 QUALITY OF LIFE-ADJUSTED SURVIVAL FOR FIRST LINE TREATMENT WITH RITUXIMAB PLUS CYCLOPHOSPHAMIDE AND VINCRISTINE (CVP) VERSUS CVP ALONE FOR PATIENTS WITH ADVANCED FOLLICULAR LYMPHOMA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)66546-1&doi=10.1016/S1098-3015(10)66546-1
First page :
Section Title :
Open access? :
No
Section Order :
381